From: Genetically proxied antidiabetic drugs targets and stroke risk
Drug class | Stroke | Gene | PP.H0 | PP.H1 | PP.H2 | PP.H3 | PP.H4 |
---|---|---|---|---|---|---|---|
Sulfonylureas | Any stroke | KCNJ11 | 1.40e−07 | 5.19e−09 | 2.08e−01 | 6.92e−03 | 0.785 |
ABCC8 | 3.09e−07 | 5.93e−09 | 2.57e−01 | 4.20e−03 | 0.739 | ||
Sulfonylureas | Any ischemic stroke | KCNJ11 | 1.62e−07 | 6.73e−09 | 2.41e−01 | 9.25e−03 | 0.750 |
ABCC8 | 3.22e−07 | 6.15e−09 | 2.68e−01 | 4.40e−03 | 0.728 |